| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $7.9B | $7.0B | $6.9B | $6.6B | $3.9B | $3.6B |
| Cost of Revenue | $5.4B | $4.8B | $5.0B | $4.8B | $3.0B | $2.8B |
| Gross Profit | $2.5B | $2.2B | $1.9B | $1.7B | $0.9B | $0.8B |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $1.9B | $1.7B | $1.6B | $1.6B | $0.8B | $0.7B |
| Operating Income | $0.6B | $0.5B | $0.4B | $0.2B | $0.1B | $-0.2B |
| Net Income | $0.3B | $0.3B | $0.2B | $0.1B | $0.0B | $-0.2B |
| EPS (Basic) | $-0.69 | $-0.84 | $-0.68 | $0.10 | $-0.67 | $-2.21 |
| EPS (Diluted) | $-0.69 | $-0.84 | $-0.68 | $0.10 | $-0.67 | $-2.21 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $8.9B | $8.2B | $7.6B | $8.1B | $5.2B | $4.1B |
| Current Assets | $3.2B | $2.7B | $2.6B | $2.7B | $2.6B | $1.4B |
| Cash & Equivalents | $0.9B | $0.5B | $0.5B | $0.6B | $1.2B | $0.5B |
| Total Liabilities | $5.5B | $5.2B | $4.7B | $5.2B | $2.8B | $2.5B |
| Current Liabilities | $2.1B | $1.9B | $1.8B | $1.9B | $0.9B | $0.8B |
| Stockholders' Equity | $3.4B | $3.0B | $2.1B | $2.1B | $2.3B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.6B | $0.5B | $0.3B | $0.2B | $0.5B |
| Investing Cash Flow | $-0.3B | $-0.8B | $-0.1B | $-2.9B | $-0.1B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.1B | $0.2B | $-0.5B | $1.8B | $0.9B | $0.1B |